M&A Deal Summary

Vitrolife Acquires MTG Medical Technology Vertriebs-

On June 1, 2016, Vitrolife acquired medical products company MTG Medical Technology Vertriebs-

Acquisition Highlights
  • This is Vitrolife’s 5th transaction in the Medical Products sector.
  • This is Vitrolife’s 2nd transaction in Germany.

M&A Deal Summary

Date 2016-06-01
Target MTG Medical Technology Vertriebs-
Sector Medical Products
Buyer(s) Vitrolife
Deal Type Add-on Acquisition

Target

MTG Medical Technology Vertriebs-

Bruckberg, Germany
website
MTG Medical Technology Vertriebs-GmbH is a developer and marketer of their own IVF products globally, primarily within the cryo-preservation, QC and andrology areas.

Search 193,448 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Vitrolife

Goteborg, Sweden

website


Category Company
Founded 1994
Sector Life Science
Employees424
Revenue 1.2B SEK (2020)
DESCRIPTION

Vitrolife is a producer and developer of products and systems for assisted reproduction worldwide. It offers fertility products, including follicle aspiration needles, paraffin oil under the OVOIL brand, additional media for in vitro fertilization (IVF) procedures, labware products, vitrification products, and Primo Vision time-lapse embryo monitoring systems. Vitrolife was founded in 1994 and is based in Gothenburg, Sweden.


DEAL STATS #
Overall 5 of 7
Sector (Medical Products) 5 of 5
Type (Add-on Acquisition) 5 of 7
Country (Germany) 2 of 2
Year (2016) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-01 OCTAX Microscience

Bruckberg, Germany

OCTAX Microscience GmbH is a developer and producer of OCTAX laser and imaging systems.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-08 Igenomix

Valencia, Spain

Igenomix engages in women’s health and reproductive genetic testing services for IVF clinics. The Company support c. 90,000 couples per year with a global footprint of 19 laboratories covering +80 countries. Igenomix was founded in 2011 and headquartered in Valencia, Spain.

Buy €1.3B